Sanstar Biopolymers Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 3.07 Cr
- Company Age 41 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 58.21%
- Profit Growth 235.77%
- Ebitda 108.07%
- Net Worth 17.35%
- Total Assets -9.50%
About Sanstar Biopolymers
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51100GJ1983PLC009047
- Company No.
009047
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Mar 1983
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sanstar Biopolymers?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gouthamchand Chowdhary  | Managing Director | 27-Sep-1985 | Current |
| Sambhav Chowdhary | Managing Director | 30-Mar-2011 | Current |
| Shreyans Chowdary | Managing Director | 30-Mar-2011 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Richa Chowdhary | Director | 05-Sep-2022 | Current |
| Sourabh Vijay | Director | 04-Sep-2021 | Current |
| Kuldeep Shah | Director | 04-Sep-2021 | Current |
Financial Performance of Sanstar Biopolymers.
Sanstar Biopolymers Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 58.21% increase. The company also saw a substantial improvement in profitability, with a 235.77% increase in profit. The company's net worth Soared by an impressive increase of 17.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanstar Biopolymers?
In 2022, Sanstar Biopolymers had a promoter holding of 98.31% and a public holding of 1.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanstar LimitedGouthamchand Chowdhary, Sambhav Chowdhary and 1 more are mutual person
Anjani Synthetics LimitedKuldeep Shah is a mutual person
Aarnav Fashions LimitedSourabh Vijay and Kuldeep Shah are mutual person
Chiripal Industries LimitedSourabh Vijay is a mutual person
Sambhav Starch Products Pvt LtdGouthamchand Chowdhary, Sambhav Chowdhary and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanstar Biopolymers?
Sanstar Biopolymers has a workforce of 8 employees as of May 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanstar Biopolymers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanstar Biopolymers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
